Market Research Reports and Industry Reports

Samsung Biologics Co Ltd (207940) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The companys business activities includes process development, contract manufacturing, aseptic fill and finish and project management. Its cell culture development process includes upstream, downstream and analytical technology. Samsung Biologics provides manufacturing and quality assurance for the clinical and commercial products. The company also provides infrastructure for partnership with other organizations to develop, refine, and distribute the bio-pharmaceutical products. It owns manufacturing facilities for cell culture development, purification, quality control, MSAT laboratory. Samsung Biologics is headquartered in Incheon, South Korea.

Samsung Biologics Co Ltd (207940) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MilliporeSigma to Enter into Agreement with Samsung Biologics 10
AstraZeneca Forms Joint Venture with Samsung Biologics 11
Bristol-Myers Squibb And Samsung BioLogics Enter Into Agreement For Antibody Cancer Drug 12
Equity Offering 13
Samsung Biologics Raises USD2.03 Billion in IPO 13
Samsung Biologics Co Ltd - Key Competitors 14
Samsung Biologics Co Ltd - Key Employees 15
Samsung Biologics Co Ltd - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Recent Developments 17
Financial Announcements 17
Apr 25, 2017: Samsung BioLogics announces its financial results for 1Q 2017 17
Jan 24, 2017: Samsung BioLogics sales and profits in 2016 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List Of Tables

List of Tables
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Samsung Biologics Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Samsung Biologics Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MilliporeSigma to Enter into Agreement with Samsung Biologics 10
AstraZeneca Forms Joint Venture with Samsung Biologics 11
Bristol-Myers Squibb And Samsung BioLogics Enter Into Agreement For Antibody Cancer Drug 12
Samsung Biologics Raises USD2.03 Billion in IPO 13
Samsung Biologics Co Ltd, Key Competitors 14
Samsung Biologics Co Ltd, Key Employees 15
Samsung Biologics Co Ltd, Joint Venture 16

Samsung Biologics Co Ltd (207940) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Samsung Biologics Co Ltd (Samsung Biologics) is a biologics development and manufacturing company. The companys business activities includes process development, contract manufacturing, aseptic fill and finish and project management. Its

USD 250View Report

Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report

Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance ReportSamsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data

USD 175View Report

Aperion Biologics Corp - Product Pipeline Analysis, 2017 Update

Aperion Biologics Corp (Aperion Biologics) is a medical device company that develops and commercializes animal-based tissue technology. The companys products include ligament reconstruction. Its Z-Process of humanizing and sterilizing tissue

USD 750View Report

Bone Biologics Corp (BBLG) - Medical Equipment - Deals and Alliances Profile

Bone Biologics Corp (Bone Biologics) is a developer of orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor which is essential for normal bone development. It offers

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :19
Country :South Korea
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube